1 LADIS Study Group. 2001–2011:a decade of the LADIS (Leukoaraiosis And DISability) Study:what have we learned about white matter changes and small-vessel disease?[J]. Cerebrovasc Dis, 2011, 32:577-588.2 Hachinski VC, Potter P, Merskey H. Leukoaraiosis[J]. Arch Neurol, 1987, 44:21-23.3 Turner ST, Jack CR, Fornage M, et al. Heritability of leukoaraiosis in hypertensive sibships[J]. Hypertension, 2004, 43:483-487.4 Schmidt R, Petrovic K, Ropele S, et al. Progression of leukoaraiosis and cognition[J]. Stroke, 2007, 38:2619-2625.5 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华高血压杂志, 2011, 19:701-743.6 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2010年版)[J]. 中国糖尿病杂志, 2012, 20:81-117.7 中华人民共和国卫生部. WS319-2010冠状动脉粥样硬化性心脏病诊断标准[S]. 北京:中国标准出版社, 2010.8 中国成人血脂异常防治指南制订联合委员会. 中国成人血脂异常防治指南[J]. 中华心血管病杂志, 2007, 35:390-419.9 中华神经科学会. 各类脑血管疾病的诊断要点[J]. 中华神经科杂志, 1996, 29:379-380.10 Smith EE. Leukoaraiosis and stroke[J]. Stroke, 2010, 41:S139-S143.11 Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT[J]. Stroke, 2001, 32:1318-1322.12 林霖, 薛蕴菁, 段青, 等. 皮质下缺血性血管病患者联络纤维的扩散张量成像分析和认知功能相关研究[J]. 中国卒中杂志, 2013, 8:614-621.13 温洪波, 张振馨, 牛福生, 等. 北京地区蒙特利尔认知量表的应用研究[J]. 中华内科杂志, 2008, 47:36-39.14 Podemski R, Pokryszko-Dragan A, Zagrajek M, et al. Mild cognitive impairment and event-related potentials in patients with cerebral atrophy and leukoaraiosis[J]. Neurol Sci, 2008, 29:411-416.15 De Groot J, de Leeuw F, Oudkerk M, et al. Cerebral white matter lesions and cognitive function:The Rotterdam Scan Study[J]. Ann Neurol, 2000, 47:145-151.16 Au R, Massaro J, Wolf P, et al. Association of white matter hyperintensity volume with decreased cognitive functioning:The Framingham Heart Study[J]. Arch Neurol, 2006, 63:246-250.17 Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline:the Austrian stroke prevention study[J]. Ann Neurol, 2005, 58:610-616.18 Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly:the Cardiovascular Health Study[J]. Stroke, 2005, 36:56-61.19 Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality:the Framingham Offspring Study[J]. Stroke, 2010, 41:600-606.20 Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period:the Leukoaraiosis and Disability study[J]. Stroke, 2008, 39:1414-1420.21 Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline[J]. N Engl J Med, 2003, 348:1215-1222.22 Kuller LH, Longstreth WT Jr, Arnold AM, et al. White matter hyperintensity on cranial magnetic resonance imaging:a predictor of stroke[J]. Stroke, 2004, 35:1821-1825.23 Henon H, Vroylandt P, Durieu I, et al. Leukoaraiosis more than dementia is a predictor of stroke recurrence[J]. Stroke, 2003, 34:2935-2940.24 Jokinen H, Schmidt R, Ropele S, et al. Diffusion changes predict cognitive and functional outcome:the LADIS study[J]. Ann Neurol, 2013, 73:576-583.25 Raji CA, Lopez OL, Kuller LH, et al. White matter lesions and brain gray matter volume in cognitively normal elders[J]. Neurobiol Aging, 2012, 33:834.e7-e16.26 Nitkunan A, Lanfranconi S, Charlton RA, et al. Brain atrophy and cerebral small vessel disease:a prospective follow-up study[J]. Stroke, 2011, 42:133-138.27 Streifler JY, Eliasziw M, Benavente OR, et al. Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis[J]. Stroke, 2002, 33:1651-1655.28 Putaala J, Haapaniemi E, Kurkinen M, et al. Silent brain infarcts, leukoaraiosis, and long-term prognosis in young ischemic stroke patients[J]. Neurology, 2011, 76:1742-1749.29 Inzitari D, Cadelo M, Marranci ML, et al. Vascular deaths in elderly neurological patients with leukoaraiosis[J]. J Neurol Neurosurg Psychiatry, 1997, 62:177-181. |